-44.1%
CHTR vs VRSK
-2.2%
-41.9%
-58.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VRSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +4.7% | +6.9% | -2.2% | +3.7% |
| 7D | +15.5% | +10.9% | +4.6% | +13.9% |
| 30D | +15.9% | +28.0% | -12.2% | +13.0% |
| 3M | -17.8% | +12.3% | -30.2% | -19.3% |
| 6M | -20.5% | +17.8% | -38.3% | -21.6% |
| YTD | -39.7% | -4.7% | -35.0% | -37.7% |
| 1Y | -44.1% | -0.2% | -43.9% | -42.0% |
| All | -44.1% | -2.2% | -41.9% | -42.0% |
Cumulative growth
Daily Returns
Daily percentage return beside VRSK.
Daily Out/Under-Performance
Portfolio return minus VRSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VRSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VRSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling